Mandate

Vinge advises on the sale of Snabboteket

November 24, 2015

Vinge has advised the sellers in connection with the sale of Snabboteket AB to Apoteket AB (publ). Snabboteket sells drugs without prescription and self-care products in small packages for inter alia the hotel and travel markets. State owned Apoteket is Sweden’s leading pharmacy operator. Snabboteket has been a Vinge Growth client since the company was founded in 2010.

From Vinge, Kristian Ford has advised the sellers of Snabboteket.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025